MATURA - Highlights and News

MAximising Therapeutic Utility in Rheumatoid Arthritis

Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue - Nature.com: Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue Nature.com
Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition - Frontiers: Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition Frontiers
Clinical implications of synovial tissue phenotypes in rheumatoid arthritis - Frontiers: Clinical implications of synovial tissue phenotypes in rheumatoid arthritis Frontiers
Rheumatoid arthritis - The Lancet: Rheumatoid arthritis The Lancet
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK - The BMJ: Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK The BMJ
Are innovation and new technologies in precision medicine paving a new era in patients centric care? - Journal of Translational Medicine: Are innovation and new technologies in precision medicine paving a new era in patients centric care? Journal of Translational Medicine
Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges - Frontiers: Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges Frontiers
A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis - Frontiers: A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis Frontiers
Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy - Frontiers: Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy Frontiers
Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes - Frontiers: Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes Frontiers

The MATURA consortium includes academic groups and industry partners working together to identify and test biomarkers
predictive of response to biological therapy in patients with rheumatoid arthritis

Highlights and News

Related